AGNES - Aging Nephropathy Study, a Prospective Observational Cohort of Chronic Kidney Disease in Elderly Patients
Ключови думи
Резюме
Дати
Последна проверка: | 09/30/2019 |
Първо изпратено: | 10/06/2019 |
Очаквано записване подадено: | 10/15/2019 |
Първо публикувано: | 10/17/2019 |
Изпратена последна актуализация: | 10/15/2019 |
Последна актуализация публикувана: | 10/17/2019 |
Действителна начална дата на проучването: | 08/31/2019 |
Приблизителна дата на първично завършване: | 09/29/2022 |
Очаквана дата на завършване на проучването: | 12/29/2022 |
Състояние или заболяване
Фаза
Критерии за допустимост
Възрасти, отговарящи на условията за проучване | 70 Years Да се 70 Years |
Полове, допустими за проучване | All |
Метод за вземане на проби | Non-Probability Sample |
Приема здрави доброволци | Да |
Критерии | - Clinical diagnosis of Chronic Kidney Disease stage 4 or 5 - Minimal age of 70 years - Must be able to understand and sign the consent form Exclusion Criteria: - Patients who did not accept and sign the consent form - Patients with cancer and life expectance lower than 6 months |
Резултат
Първични изходни мерки
1. Mortality [through study completion, an average of 2 years]
2. Renal replacement therapy initiation [through study completion, an average of 2 years]
Вторични изходни мерки
1. Fragility [through study completion, an average of 2 years]
2. Sleep disorder based on polysomnography [through study completion, an average of 2 years]
3. Sleep disorder - somnolence [through study completion, an average of 2 years]
4. Sleep disorder - subjective quality of sleep [through study completion, an average of 2 years]
5. Sleep disorder - objective quality of sleep [through study completion, an average of 2 years]
6. Cognition [through study completion, an average of 2 years]
7. Nutrition [through study completion, an average of 2 years]
8. Nutrition [through study completion, an average of 2 years]
9. Nutrition [through study completion, an average of 2 years]
10. Nutrition [through study completion, an average of 2 years]
11. Mineral and bone markers [through study completion, an average of 2 years]